GO:0051287 NAD binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051287 (NAD binding) is a molecular function describing binding to nicotinamide adenine dinucleotide, either oxidized NAD+ or reduced NADH.
• NAD binding is mediated by conserved structural motifs and is central to redox reactions, DNA repair, and transcriptional regulation.
• Proteins such as CtBP1 and CtBP2 require NADH/NAD+ binding for tetrameric assembly and oncogenic function.
• NAD+ riboswitches sense NAD+ levels through distinct ligand-binding pockets, controlling gene expression in bacteria.
• The MERS-CoV macro domain binds NAD metabolites, highlighting viral exploitation of NAD binding.
• NAMPT employs a switch that senses AMP/ATP and regulates cellular responses to energy stress via NAD binding.
Description
NAD binding (GO:0051287) is a fundamental molecular function that enables proteins to interact with nicotinamide adenine dinucleotide (NAD+ or NADH), a coenzyme involved in numerous redox and biosynthetic reactions. This binding event is critical for cellular processes ranging from energy metabolism to gene regulation and DNA repair. Researchers study NAD binding to understand how proteins sense metabolic states and how dysregulation contributes to diseases such as cancer and viral infections [1, 5]. The QuickGO definition states that NAD binding is the binding to nicotinamide adenine dinucleotide, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NAD+, or the reduced form, NADH. This article explores the mechanisms, key genes, and research methods associated with NAD binding, providing a comprehensive resource for biomedical researchers.
NAD binding At A Glance
| GO ID | GO:0051287 |
|---|---|
| GO term | NAD binding |
| Ontology | molecular_function |
| Synonym | NAD or NADH binding; NAD+ or NADH binding; nicotinamide adenine dinucleotide binding |
| Major function | Binding to nicotinamide adenine dinucleotide (NAD+ or NADH), a coenzyme in redox and biosynthetic reactions |
| Definition source | QuickGO |
| Related processes | Redox reactions, DNA repair, transcriptional regulation, energy stress responses |
What Is GO:0051287?
NAD binding (GO:0051287) is a molecular function defined as the selective interaction with nicotinamide adenine dinucleotide (NAD+ or NADH). This binding is non-covalent and reversible, allowing proteins to utilize NAD as a cofactor in redox reactions, as a substrate for ADP-ribosylation, or as a signaling molecule [1, 4]. The term encompasses binding to both oxidized and reduced forms, reflecting the diverse roles of NAD in cellular metabolism and regulation.
Why Is NAD binding Important in Cell Biology?
NAD binding is essential for cellular energy metabolism, signaling, and genome stability. Proteins that bind NAD are involved in diverse physiological processes, and their dysfunction is linked to cancer, neurodegeneration, and infectious diseases [1, 5, 8]. Understanding NAD binding mechanisms can reveal therapeutic targets and guide drug discovery.
• NAD binding is required for redox reactions in glycolysis, oxidative phosphorylation, and biosynthetic pathways.
• It regulates transcriptional corepressors such as CtBP1/2, which are oncogenic when dysregulated.
• NAD+ riboswitches control bacterial gene expression in response to NAD+ levels.
• Viral proteins like the MERS-CoV macro domain bind NAD metabolites to evade host immunity.
• NAMPT senses AMP/ATP via NAD binding to regulate energy stress responses.
• NAD binding is critical for DNA repair enzymes like PARPs and sirtuins.
• Dysregulated NAD binding contributes to metabolic disorders and cancer [1, 8].
• Targeting NAD binding sites is a strategy for antibacterial and antiviral drug development [4, 5].
Molecular Mechanism of NAD binding
NAD Binding Motifs and Structural Recognition
In simple terms: Proteins use specific structural patterns to grab onto NAD.
NAD binding proteins often contain conserved sequence motifs, such as the Rossmann fold or the NAD(P)-binding motif, which facilitate specific recognition of the adenine and nicotinamide moieties. These motifs enable hydrogen bonding and hydrophobic interactions that stabilize the NAD-protein complex.
Conformational Changes upon NAD Binding
In simple terms: When NAD binds, the protein changes shape to perform its function.
Binding of NAD+ or NADH induces conformational changes in target proteins. For example, CtBP1 and CtBP2 undergo linked tetrameric assembly upon NADH/NAD+ binding, which is essential for their oncogenic transcription factor activity. Similarly, NAD+ riboswitches undergo structural rearrangements that modulate gene expression.
NAD Binding in Redox Catalysis
In simple terms: NAD acts as a shuttle for electrons in many chemical reactions.
NAD binding enables enzymes to transfer electrons in redox reactions. The nicotinamide ring of NAD accepts or donates hydride ions, facilitating oxidation-reduction reactions critical for metabolism. This mechanism is conserved across dehydrogenases and oxidoreductases.
NAD Binding in Signaling and Regulation
In simple terms: NAD binding also helps cells sense energy levels and respond.
Beyond redox, NAD binding mediates signaling. The NAMPT enzyme employs a switch that directly senses AMP/ATP and regulates cellular responses to energy stress via NAD binding. Additionally, NAD+ riboswitches in bacteria sense NAD+ concentrations to control gene expression.
Viral and Pathogen Exploitation of NAD Binding
In simple terms: Some pathogens use NAD binding to attack host defenses.
The MERS-CoV macro domain binds NAD metabolites, which may help the virus evade host immunity. Shigella effector OspC3 binds NAD to ADP-riboxanate caspase-4/11, blocking pyroptosis. These examples highlight NAD binding as a target for antiviral and antibacterial strategies [4, 5].
Key Genes Involved in GO:0051287 NAD binding
The following genes encode proteins with NAD binding activity (GO:0051287) and are key to understanding its biological roles.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CTBP1 | Transcriptional corepressor; requires NADH/NAD+ binding for tetramerization | Oncogenic roles in cancer; studied for NAD-dependent assembly |
| CTBP2 | Transcriptional corepressor; NADH/NAD+ binding linked to tetrameric assembly | Implicated in cancer and developmental disorders |
| NAMPT | Rate-limiting enzyme in NAD biosynthesis; senses AMP/ATP via NAD binding | Target for metabolic diseases and cancer |
| NadR | Bifunctional regulator in Salmonella; NAD-dependent DNA-binding activity | Model for NAD-controlled gene regulation |
| Macro domain (MERS-CoV) | Binds NAD metabolites to modulate host immune response | Antiviral target; studied for NAD binding specificity |
| OspC3 | Shigella effector; binds NAD to modify caspase-4/11 | Bacterial pathogenesis; NAD-dependent ADP-riboxanation |
| NAD+ riboswitch | RNA element that binds NAD+ to regulate gene expression | Antibacterial target; structural studies of NAD binding |
| NAD+-II riboswitch | Binds NAD+ with two distinct pockets | RNA-based regulation; ligand binding studies |
| Sirtuins (e.g., SIRT1) | NAD+-dependent deacetylases | Aging, metabolism, and cancer research |
| PARPs | NAD+-dependent poly(ADP-ribose) polymerases | DNA repair and cancer therapy |
| GAPDH | NAD+-dependent glyceraldehyde-3-phosphate dehydrogenase | Glycolysis and metabolic studies |
| LDH | NAD(H)-dependent lactate dehydrogenase | Metabolic reprogramming in cancer |
| MDH | NAD+-dependent malate dehydrogenase | TCA cycle and energy metabolism |
| IDH | NAD+-dependent isocitrate dehydrogenase | Cancer metabolism and mutations |
| ALDH | NAD+-dependent aldehyde dehydrogenase | Detoxification and stem cell biology |
| NADSYN1 | NAD synthetase; binds NAD precursors | NAD homeostasis and disease |
How Is NAD binding Regulated?
NAD binding activity is regulated by cellular NAD+ and NADH levels, which fluctuate with metabolic state. The NAMPT enzyme senses AMP/ATP ratios and adjusts NAD synthesis accordingly, thereby influencing NAD binding by downstream proteins. Additionally, NAD+ riboswitches respond to intracellular NAD+ concentrations to control gene expression. Post-translational modifications and protein-protein interactions can also modulate NAD binding affinity.
NAD binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CTBP1 | Cancer (transcriptional corepression) | Knockout and point-mutation cell lines to disrupt NAD binding |
| CTBP2 | Cancer and developmental disorders | Knock-in of NAD-binding deficient mutants |
| NAMPT | Metabolic disorders and cancer | Overexpression and knockout models to study energy stress |
| MERS-CoV macro domain | Viral infection | Point mutations in NAD-binding pocket to test immune evasion |
| OspC3 | Bacterial pathogenesis | Knockout of NAD-binding activity in Shigella |
NAD Binding in Cancer
Dysregulated NAD binding contributes to cancer through altered metabolism and gene expression. CtBP1 and CtBP2 require NADH/NAD+ binding for tetrameric assembly and oncogenic activity, making them potential therapeutic targets. NAMPT, which senses energy stress via NAD binding, is often overexpressed in cancers and supports tumor growth.
NAD Binding in Infectious Diseases
Pathogens exploit NAD binding to subvert host immunity. The MERS-CoV macro domain binds NAD metabolites to counteract antiviral responses. Shigella effector OspC3 binds NAD to ADP-riboxanate caspase-4/11, blocking pyroptosis and facilitating infection. These interactions highlight NAD binding as a vulnerability for antiviral and antibacterial drug development [4, 5].
NAD Binding in Metabolic Disorders
NAD binding is central to energy metabolism, and its dysregulation is linked to metabolic disorders such as diabetes and obesity. NAMPT-mediated NAD binding senses AMP/ATP and regulates cellular responses to energy stress, influencing insulin sensitivity and metabolic homeostasis.
From NAD binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NAD binding affect protein function? | Knockout cell lines (e.g., CTBP1 KO) |
| How does a specific NAD-binding residue contribute to activity? | Point-mutation knock-in (e.g., NAD-binding site mutation) |
| Can NAD binding be tracked in live cells? | Tagged knock-in with fluorescent protein |
| What is the effect of NAD binding on gene expression? | Overexpression of wild-type vs. NAD-binding mutant |
| How does NAD binding influence energy stress responses? | NAMPT overexpression and knockout models |
| Can we screen for drugs targeting NAD binding? | CRISPR library screening with NAD-binding domain reporters |
How to Study the NAD binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | 3D structure of NAD-protein complex | Determining binding pocket and conformational changes |
| FRET | Binding affinity and conformational dynamics | Real-time NAD binding studies |
| Biolayer interferometry | Binding kinetics (kon, koff) | Comparing wild-type and mutant NAD binding |
| RNA-seq | Gene expression changes | Assessing transcriptional effects of NAD binding |
| CRISPR screening | Genes required for NAD binding-dependent growth | Identifying therapeutic targets |
| Mass spectrometry | NAD-binding protein identification | Proteome-wide profiling |
| Metabolomics | NAD+ and NADH levels | Correlating metabolism with binding activity |
Structural Biology Methods
X-ray crystallography and cryo-EM are used to determine the atomic structures of NAD-protein complexes, revealing binding pockets and conformational changes [1, 3]. These methods are essential for understanding how NAD binding mediates function.
Biophysical Binding Assays
FRET and biolayer interferometry (BLI) measure NAD binding affinity and kinetics in real time. These techniques are valuable for characterizing mutant proteins and screening inhibitors.
Genomic and Transcriptomic Approaches
RNA-seq and ribosome profiling can assess how NAD binding affects gene expression programs, especially for transcription factors like CtBP1/2. CRISPR screens can identify genes required for NAD binding-dependent phenotypes.
Proteomic and Metabolomic Profiling
Mass spectrometry-based proteomics can identify NAD-binding proteins, while metabolomics quantifies NAD+ and NADH levels to correlate with binding activity.
How CRISPR Can Be Used to Study GO:0051287 NAD binding
Knockout
CRISPR knockout of genes encoding NAD-binding proteins (e.g., CTBP1, NAMPT) can reveal their essential functions and validate them as drug targets [1, 8]. Knockout cell lines are used to study loss of NAD binding on metabolism and gene expression.
Point Mutation
Introducing point mutations in NAD-binding motifs (e.g., in CTBP1 or viral macro domains) allows precise dissection of binding residues without affecting protein stability [1, 5]. These models are crucial for understanding structure-function relationships.
Knock-in
Knock-in of tagged or reporter versions of NAD-binding proteins enables live-cell imaging and tracking of NAD binding dynamics. This approach can also be used to introduce disease-associated mutations.
Overexpression
Overexpression of wild-type or NAD-binding mutant proteins helps determine gain-of-function effects and dominant-negative phenotypes [1, 8]. This is particularly useful for studying oncogenic transcription factors like CtBP1/2.
How EDITGENE Supports NAD binding Research
Researchers studying NAD binding-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, and CRISPR-based models provide the most direct way to test this. EDITGENE offers a comprehensive suite of services to accelerate such studies.
Contact EDITGENE today to design your custom CRISPR model for NAD binding research.
Frequently Asked Questions About NAD binding
What is NAD binding (GO:0051287)?
NAD binding is a molecular function defined as the binding to nicotinamide adenine dinucleotide (NAD+ or NADH), a coenzyme involved in redox and biosynthetic reactions.
What genes are involved in NAD binding?
Genes encoding NAD-binding proteins include CTBP1, CTBP2, NAMPT, NadR, and many metabolic enzymes like GAPDH and LDH [1, 4, 6, 8].
How does NAD binding regulate transcription?
NAD binding can induce conformational changes in transcription factors like CtBP1/2, promoting tetramerization and corepressor activity.
What diseases are associated with NAD binding?
Dysregulated NAD binding is linked to cancer, infectious diseases, and metabolic disorders [1, 5, 8].
What methods are used to study NAD binding?
Common methods include X-ray crystallography, FRET, biolayer interferometry, RNA-seq, and CRISPR screening [1, 2, 4].
Can CRISPR be used to study NAD binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect NAD binding functions [1, 5].
What is the role of NAD binding in viral infection?
Viral proteins like the MERS-CoV macro domain bind NAD metabolites to evade host immunity.
How is NAD binding regulated?
NAD binding is regulated by cellular NAD+ and NADH levels, which are sensed by enzymes like NAMPT and riboswitches [3, 8].
What are the key structural motifs for NAD binding?
Conserved motifs include the Rossmann fold and NAD(P)-binding motif, which recognize the adenine and nicotinamide moieties.
Why is NAD binding important for drug discovery?
NAD binding sites are attractive targets for antibacterial, antiviral, and anticancer drugs [4, 5].
Conclusion
NAD binding (GO:0051287) is a central molecular function that underpins redox metabolism, gene regulation, and immune evasion. Understanding its mechanisms and key genes provides insights into human diseases and offers opportunities for therapeutic intervention. EDITGENE's CRISPR services empower researchers to dissect NAD binding pathways with precision and scale.
References
- 1. Erlandsen H et al.. 2022. NADH/NAD(+) binding and linked tetrameric assembly of the oncogenic transcription factors CtBP1 and CtBP2.. FEBS Lett 596(4):479-490 PMID: 34997967
- 2. Conoan Nieves NE et al.. 2024. Ligand binding characteristics of an NAD(+) riboswitch revealed by FRET and biolayer interferometry.. Chem Commun (Camb) 61(2):346-349 PMID: 39635865
- 3. Peng X et al.. 2023. Crystal structures of the NAD+-II riboswitch reveal two distinct ligand-binding pockets.. Nucleic Acids Res 51(6):2904-2914 PMID: 36840714
- 4. Hua YH et al.. 2014. Sequence-motif detection of NAD(P)-binding proteins: discovery of a unique antibacterial drug target.. Sci Rep 4:6471 PMID: 25253464
- 5. Lin MH et al.. 2021. Elucidating the tunability of binding behavior for the MERS-CoV macro domain with NAD metabolites.. Commun Biol 4(1):123 PMID: 33504944
- 6. Penfound T et al.. 1999. NAD-dependent DNA-binding activity of the bifunctional NadR regulator of Salmonella typhimurium.. J Bacteriol 181(2):648-55 PMID: 9882682
- 7. Hou Y et al.. 2023. Structural mechanisms of calmodulin activation of Shigella effector OspC3 to ADP-riboxanate caspase-4/11 and block pyroptosis.. Nat Struct Mol Biol 30(3):261-272 PMID: 36624349
- 8. Zu Y et al.. 2025. The NAMPT enzyme employs a switch that directly senses AMP/ATP and regulates cellular responses to energy stress.. Mol Cell 85(12):2271-2286.e6 PMID: 40505662
